Status:
UNKNOWN
Photodynamic Therapy for the Treatment of COVID-19
Lead Sponsor:
Cairo University
Conditions:
Photodynamic Therapy& Low Level Laser in Management of COVID 19
Eligibility:
All Genders
Phase:
NA
Brief Summary
Until now there is no vaccine or reliable treatment for the COVID-19 pandemic. The fundamental mechanisms of non-invasive low-level laser in photobiomodulation (PBM) and photodynamic therapy is to sti...
Detailed Description
Treatment protocol: This clinical study was conducted following the approval of the research ethics committee for experimental and clinical studies at the National Institute of Laser Enhanced Science...
Eligibility Criteria
Inclusion
- Hospitalized patients with Positive COVID 19 test suffering from Fever, cough, shortness of breath, chills, muscle pain, the new loss of taste or smell, vomiting or diarrhea, and/or sore throat
Exclusion
- Patients in critical cases who admitted to the ICU, bacterial pneumonia, and respiratory distress grade III, IV, and patients on a mechanical ventilator.
Key Trial Info
Start Date :
August 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04416113
Start Date
August 5 2021
End Date
February 1 2022
Last Update
August 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abeer Attia Tawfik
Giza, Egypt, 11236